Detalhe da pesquisa
1.
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Cell;
182(3): 685-712.e19, 2020 08 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32645325
2.
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
J Allergy Clin Immunol;
147(2): 545-557.e9, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33221383
3.
Human MxB Protein Is a Pan-herpesvirus Restriction Factor.
J Virol;
92(17)2018 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29950411
4.
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.
Nat Commun;
14(1): 1999, 2023 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37037847
5.
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2.
NPJ Vaccines;
7(1): 82, 2022 Jul 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35879345
6.
The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.
Elife;
112022 04 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35475759
7.
Antibody escape and global spread of SARS-CoV-2 lineage A.27.
Nat Commun;
13(1): 1152, 2022 03 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35241661
8.
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.
Nat Commun;
12(1): 6405, 2021 11 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34737266
9.
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
JAMA Pediatr;
175(6): 586-593, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33480966
10.
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.
Cell Rep Med;
1(8): 100142, 2020 11 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33163980
11.
CHIPMUNK: A Virtual Synthesizable Small-Molecule Library for Medicinal Chemistry, Exploitable for Protein-Protein Interaction Modulators.
ChemMedChem;
13(6): 532-539, 2018 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29392860
12.
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.
J Allergy Clin Immunol Pract;
10(9): 2452-2455.e3, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35779780